Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Materials
Create a narrative
Tatva Chintan Pharma Chem Community
NSEI:TATVA Community
1
Narratives
written by author
0
Comments
on narratives written by author
5
Fair Values set
on narratives written by author
Create a narrative
Tatva Chintan Pharma Chem
Popular
Undervalued
Overvalued
Community Investing Ideas
Tatva Chintan Pharma Chem
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
New Product Launches Will Strengthen Future Market Prospects
Key Takeaways Expansion in Phase Transfer Catalyst and Structure Directing Agents segments could boost revenue and net margins as demand recovers and new customers onboard. New product commercialization in agrochemical and pharma intermediates and focus on high-value segments like semiconductors may significantly increase future growth.
View narrative
₹742.00
FV
34.8% overvalued
intrinsic discount
16.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
TATVA
TATVA
Tatva Chintan Pharma Chem
Your Fair Value
₹
Current Price
₹1.00k
13.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
9b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹8.7b
Earnings ₹129.9m
Advanced
Set Fair Value